Black Lungs Symptoms

Black Lung Symptoms

Black lung disease can have a variety of symptoms depending on how far the condition has progressed. In many cases, individuals with black lung do not experience any noticeable symptoms in the early stages of the disease, although they may be more susceptible to developing respiratory tract infections, such as bronchitis, during this time. This early period is commonly referred to as asymptomatic anthracosis. Over time, however, individuals affected by the condition may develop chronic coughing and shortness of breath, along with the following:

  • Airway obstruction
  • Increased production of mucus/sputum
  • Pain while breathing
  • Pulmonary hypertension

When left untreated, or with continued exposure to coal mine dust, the condition can continue to progress and cause further complications. For instance, an afflicted individual may begin to cough up blood (hemoptysis) or produce black mucus (melanoptysis). The resulting lung damage may lead to the development of chronic bronchitis, chronic obstructive pulmonary disease (COPD), lung cancer or respiratory failure.

If an individual with black lung disease also has rheumatoid arthritis, he or she may develop Caplan’s syndrome, which, in addition to the above-listed symptoms, may lead to painful and swollen joints and the development of round nodules throughout the lungs. Overall, individuals with black lung experience a significant decrease in their quality of life.

If you’re living with black lung disease and dealing with its impactful symptoms, you may be interested in stem cell therapy. Please contact the Lung Institute at (800) 729-3065 to learn how our innovative stem cell treatment may be able to help relieve your symptoms and potentially even slow the progression of the disease. Our goal is to help you breathe easier, and our knowledgeable team is fully equipped to answer any questions you may have.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.